Correlates of baseline platelet function as measured by the Ultegra-RPFA and its asssociation with the level of platelet inhibition achieved with GPIIb/IIIa inhibitor therapy. Results from the GOLD study.
Publication
, Journal Article
Steinhubl, SR; Talley, JD; Kereiakes, DJ; Braden, GA; Tcheng, JE; Casterella, PJ; Moliterno, DJ; Navetta, FI; Berger, PB; Popma, JJ; Dangas, GD ...
Published in: CIRCULATION
October 31, 2000
Duke Scholars
Published In
CIRCULATION
ISSN
0009-7322
Publication Date
October 31, 2000
Volume
102
Issue
18
Start / End Page
418 / 419
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Related Subject Headings
- Cardiovascular System & Hematology
- 4207 Sports science and exercise
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Steinhubl, S. R., Talley, J. D., Kereiakes, D. J., Braden, G. A., Tcheng, J. E., Casterella, P. J., … Theroux, P. (2000). Correlates of baseline platelet function as measured by the Ultegra-RPFA and its asssociation with the level of platelet inhibition achieved with GPIIb/IIIa inhibitor therapy. Results from the GOLD study. CIRCULATION, 102(18), 418–419.
Steinhubl, S. R., J. D. Talley, D. J. Kereiakes, G. A. Braden, J. E. Tcheng, P. J. Casterella, D. J. Moliterno, et al. “Correlates of baseline platelet function as measured by the Ultegra-RPFA and its asssociation with the level of platelet inhibition achieved with GPIIb/IIIa inhibitor therapy. Results from the GOLD study.” CIRCULATION 102, no. 18 (October 31, 2000): 418–19.
Steinhubl SR, Talley JD, Kereiakes DJ, Braden GA, Tcheng JE, Casterella PJ, et al. Correlates of baseline platelet function as measured by the Ultegra-RPFA and its asssociation with the level of platelet inhibition achieved with GPIIb/IIIa inhibitor therapy. Results from the GOLD study. CIRCULATION. 2000 Oct 31;102(18):418–9.
Steinhubl, S. R., et al. “Correlates of baseline platelet function as measured by the Ultegra-RPFA and its asssociation with the level of platelet inhibition achieved with GPIIb/IIIa inhibitor therapy. Results from the GOLD study.” CIRCULATION, vol. 102, no. 18, LIPPINCOTT WILLIAMS & WILKINS, Oct. 2000, pp. 418–19.
Steinhubl SR, Talley JD, Kereiakes DJ, Braden GA, Tcheng JE, Casterella PJ, Moliterno DJ, Navetta FI, Berger PB, Popma JJ, Dangas GD, Theroux P. Correlates of baseline platelet function as measured by the Ultegra-RPFA and its asssociation with the level of platelet inhibition achieved with GPIIb/IIIa inhibitor therapy. Results from the GOLD study. CIRCULATION. LIPPINCOTT WILLIAMS & WILKINS; 2000 Oct 31;102(18):418–419.
Published In
CIRCULATION
ISSN
0009-7322
Publication Date
October 31, 2000
Volume
102
Issue
18
Start / End Page
418 / 419
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Related Subject Headings
- Cardiovascular System & Hematology
- 4207 Sports science and exercise
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology